日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

Fc优化的CD40激动性抗体可诱导转移性癌症中三级淋巴结构形成和全身抗肿瘤免疫。

Juan C Osorio ,David A Knorr ,Polina Weitzenfeld ,Lucas Blanchard ,Ning Yao ,Maria Baez ,Carlo Sevilla ,Meghan DiLillo ,Jahan Rahman ,Ved P Sharma ,Jacqueline Bromberg ,Michael A Postow ,Charlotte Ariyan ,Mark E Robson ,Jeffrey V Ravetch

Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade

Fc优化的抗CTLA-4抗体可增加肿瘤相关高内皮静脉的数量,并使难治性肿瘤对PD-1阻断疗法更加敏感。

Lucas Blanchard ,Estefania Vina ,Jerko Ljubetic ,Cécile Meneur ,Dorian Tarroux ,Maria Baez ,Alessandra Marino ,Nathalie Ortega ,David A Knorr ,Jeffrey V Ravetch ,Jean-Philippe Girard

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

FcγRIIB是一种免疫检查点,可限制肿瘤微环境中靶向Treg细胞的抗体的活性。

David A Knorr # ,Lucas Blanchard # ,Rom S Leidner # ,Shawn M Jensen ,Ryan Meng ,Andrew Jones ,Carmen Ballesteros-Merino ,Richard B Bell ,Maria Baez ,Alessandra Marino ,David Sprott ,Carlo B Bifulco ,Brian Piening ,Rony Dahan ,Juan C Osorio ,Bernard A Fox ,Jeffrey V Ravetch

Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer

肿瘤内 Fc 优化的激动性 CD40 抗体在转移性癌症患者中诱导肿瘤排斥和全身抗肿瘤免疫

Juan C Osorio, David A Knorr, Polina Weitzenfeld, Ning Yao, Maria Baez, Meghan DiLillo, Jahan Rahman, Jacqueline Bromberg, Michael A Postow, Charlotte Ariyan, Mark E Robson, Jeffrey V Ravetch

Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia

对 AML 相关抗原的系统评估确定了用于治疗急性髓系白血病的抗 U5 SNRNP200 治疗性抗体

Katherine Knorr, Jahan Rahman, Caroline Erickson, Eric Wang, Mara Monetti, Zhuoning Li, Juliana Ortiz-Pacheco, Andrew Jones, Sydney X Lu, Robert F Stanley, Maria Baez, Nina Fox, Cynthia Castro, Alessandra E Marino, Caroline Jiang, Alex Penson, Simon J Hogg, Xiaoli Mi, Hideaki Nakajima, Hiroyoshi Kun

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

FcyRIIB 是肿瘤微环境中限制 Treg 靶向抗体活性的新型免疫检查点

David Knorr, Rom Leidner, Shawn Jensen, Ryan Meng, Andrew Jones, Carmen Ballesteros-Merino, R Bryan Bell, Maria Baez, David Sprott, Carlo Bifulco, Brian Piening, Rony Dahan, Bernard A Fox, Jeffrey Ravetch